Circulation Research · 2014 · 152 citations · 37 references
Life SciencesCardiologyInfectious DiseasesMolecular VirologyStem Cell BiologyVirologyAntiviral PharmacologyAntiviral TherapyViral InfectionsViral PathogenesisViral PathologyAntiviral Drug MechanismsAntiviral TherapeuticsCoxsackievirus InfectionsHuman Stem Cell ModelsStem Cell-derived CardiomyocytesViral MyocarditisViral Therapeutic Targets
RATIONALE: Viral myocarditis is a life-threatening illness that may lead to heart failure or cardiac arrhythmias. A major causative agent for viral myocarditis is the B3 strain of coxsackievirus, a positive-sense RNA enterovirus. However, human cardiac tissues are difficult to procure in sufficient enough quantities for studying the mechanisms of cardiac-specific viral infection. OBJECTIVE: This study examined whether human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) could be used to model the pathogenic processes of coxsackievirus-induced viral myocarditis and to screen antiviral therapeutics for efficacy. METHODS AND RESULTS: hiPSC-CMs were infected with a luciferase-expressing coxsackievirus B3 strain (CVB3-Luc). Brightfield microscopy, immunofluorescence, and calcium imaging were used to characterize virally infected hiPSC-CMs for alterations in cellular morphology and calcium handling. Viral proliferation in hiPSC-CMs was quantified using bioluminescence imaging. Antiviral compounds including interferonβ1, ribavirin, pyrrolidine dithiocarbamate, and fluoxetine were tested for their capacity to abrogate CVB3-Luc proliferation in hiPSC-CMs in vitro. The ability of these compounds to reduce CVB3-Luc proliferation in hiPSC-CMs was consistent with reported drug effects in previous studies. Mechanistic analyses via gene expression profiling of hiPSC-CMs infected with CVB3-Luc revealed an activation of viral RNA and protein clearance pathways after interferonβ1 treatment. CONCLUSIONS: This study demonstrates that hiPSC-CMs express the coxsackievirus and adenovirus receptor, are susceptible to coxsackievirus infection, and can be used to predict antiviral drug efficacy. Our results suggest that the hiPSC-CM/CVB3-Luc assay is a sensitive platform that can screen novel antiviral therapeutics for their effectiveness in a high-throughput fashion.
37
Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells
Junying Yu, Maxim A. Vodyanik, Kim Smuga-Otto et al. · Science · 2007 · 10.3K citations
Sudden Deaths in Young Competitive Athletes
Barry J. Maron, Joseph J. Doerer, Tammy S. Haas et al. · Circulation · 2009 · 2.1K citations · Full text
Xiaojun Lian, Cheston Hsiao, Gisela F. Wilson et al. · Proceedings of the National Academy of Sciences · 2012 · 1.8K citations · Full text
William C. Claycomb, Nicholas A. Lanson, Beverly S. Stallworth et al. · Proceedings of the National Academy of Sciences · 1998 · 1.5K citations